MelaVV™ · Hair Restoration Platform
Treatment you'll actually keep doing.
Immediate coverage. Lasting results. Nothing to hide.
Treatments for hair loss work. The clinical evidence is clear and has been for decades. But clinical outcomes depend entirely on whether patients keep using the treatment consistently — and that has always been the real problem.
For many patients — men and women alike — daily topical treatment is visually conspicuous. It changes how hair looks. It changes how hair feels. It is a daily, visible reminder of something most people would rather not think about. They start. They stop. The results never come.
This is not a pharmacology problem. It has never been. The treatments work. The experience of using them, for too many patients, does not.
The gap between what hair restoration treatments can do and what they actually deliver has always been a question of consistent daily use. MelaVV™ was built to close it.
MelaVV™ delivers immediate, natural-looking results from the very first application — while maintaining continuous therapeutic efficacy. One product. Both outcomes. Designed from the ground up so that staying on treatment is the path of least resistance.
When treatment is invisible, the decision to keep using it disappears.
Most hair restoration treatments ask patients to accept visible evidence of their condition every day. MelaVV™ removes that requirement entirely.
Topical minoxidil market by 2032 — up from $1.1B in 2023 · CAGR 9.1%
Global hair loss treatment market by 2031 — up from $3.8B in 2024 · CAGR 6.9%
Consistent daily use is the dominant clinical challenge across the category. MelaVV™ addresses the market’s largest unmet need: not a new molecule, a new patient experience built around the proven molecule.
Two US patent applications pending.
Immediate coverage, lasting results, and nothing to hide.
Connect With Us